CompletedNCT03960385

Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

Studying Dengue fever

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Albert B. Sabin Vaccine Institute
Principal Investigator
Denise O Garrett, MD, MSc
Albert B. Sabin Vaccine Institute
Intervention
CYD-TDV(biological)
Enrollment
1854 enrolled
Eligibility
9-44 years · All sexes
Timeline
2017 – 2020

Study locations (1)

Collaborators

Pan American Health Organization · State of Parana/Health Department of Parana · Ministry of Health, Brazil · Centro de Estudos Augusto Leopoldo Ayrosa Galvão

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03960385 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever →

← Back to all trials